Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding round raising $12.2 million. The Seed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback